| pubmed-article:9862047 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C0024881 | lld:lifeskim |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:9862047 | lifeskim:mentions | umls-concept:C1514873 | lld:lifeskim |
| pubmed-article:9862047 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:9862047 | pubmed:dateCreated | 1999-2-25 | lld:pubmed |
| pubmed-article:9862047 | pubmed:abstractText | A prospective randomised trial was undertaken to evaluate the role of neoadjuvant chemoendocrine therapy prior to surgery in primary operable breast cancer. | lld:pubmed |
| pubmed-article:9862047 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9862047 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9862047 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9862047 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9862047 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9862047 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9862047 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:9862047 | pubmed:author | pubmed-author:PowlesT JTJ | lld:pubmed |
| pubmed-article:9862047 | pubmed:author | pubmed-author:ChangJJ | lld:pubmed |
| pubmed-article:9862047 | pubmed:author | pubmed-author:FordH THT | lld:pubmed |
| pubmed-article:9862047 | pubmed:author | pubmed-author:NashA GAG | lld:pubmed |
| pubmed-article:9862047 | pubmed:author | pubmed-author:MakrisAA | lld:pubmed |
| pubmed-article:9862047 | pubmed:author | pubmed-author:AshleyS ESE | lld:pubmed |
| pubmed-article:9862047 | pubmed:author | pubmed-author:HickishTT | lld:pubmed |
| pubmed-article:9862047 | pubmed:author | pubmed-author:TidyV AVA | lld:pubmed |
| pubmed-article:9862047 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9862047 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:9862047 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9862047 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9862047 | pubmed:pagination | 1179-84 | lld:pubmed |
| pubmed-article:9862047 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:meshHeading | pubmed-meshheading:9862047-... | lld:pubmed |
| pubmed-article:9862047 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9862047 | pubmed:articleTitle | A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. | lld:pubmed |
| pubmed-article:9862047 | pubmed:affiliation | Royal Marsden Hospital, Sutton, Surrey, UK. | lld:pubmed |
| pubmed-article:9862047 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9862047 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9862047 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9862047 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9862047 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9862047 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9862047 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9862047 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9862047 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9862047 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9862047 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9862047 | lld:pubmed |
